‘A very good clone’: news stories faked to lure victims to scam investment sites
THE SO WHAT
High-fidelity fake news articles mimicking outlets like the Guardian to drive investment scams show that media brands are now attack surfaces, not just assets. Financial services and publishers should assume their logos and layouts will be cloned—and invest in provenance, verification UX, and rapid takedown muscle.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechPhysicists recreate black hole energy extraction in the lab
Turning a long-theoretical black hole energy extraction mechanism into a tabletop experiment opens a new design space for extreme optics and wireless power concepts. Deep-tech teams in photonics and energy transfer should watch this as a potential source of non-obvious IP and architectures over the next decade, not a near-term product.
Deep & Emerging TechThe DIY energy boom is here — 30 US states are planning to legalize plug-in solar tech, as home battery installations quietly hit a record high
Plug-in solar and record home battery installs point to a bottom-up grid transition—households are turning into micro-utilities without waiting for rooftop installs or utility programs. Energy and hardware operators should assume a more fragmented, prosumer-heavy landscape and design products that interoperate with ad hoc home setups, not just utility-scale deployments.
Deep & Emerging TechI helped drive this record-setting EV across Britain on sunshine alone — and the 870-mile trip cost absolutely nothing
An 870-mile, grid-free EV run is less about stunts and more about routing and storage math catching up to real-world use. If you’re in mobility or energy, start modeling business cases where solar, batteries, and software arbitrage grid dependence rather than replace it outright.
Deep & Emerging TechScientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides
AI plus early-stage quantum used to design new peptides for rare diseases is a preview of drug discovery moving from lab-first to compute-first. Biotech operators should map where hybrid classical/quantum workflows could compress target ID and lead optimization long before wet-lab capacity becomes the bottleneck.